Nerai Bioscience AG
PrivateLast Round
Seed
May 1, 2025
Total Funding Raised
$4.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nerai Bioscience AG operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Seed round in May 2025.
Nerai Bioscience AG is a biotechnology company that pioneers novel, highly personalized CRISPR proteins to deliver cures for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nerai Bioscience AG Comparables
Compare Nerai Bioscience AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scribe Therapeutics | 77% | |
| Arbor Biotechnologies | 77% | |
| Mammoth Biosciences | 77% |
For institutional investors. Book with your work email.
Nerai Bioscience AG Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nerai Bioscience AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Seed |
| Kickfund | Seed |
| Swiss National Science Foundation | Seed |
| Venture Kick | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 285% MoM, reaching 335.
- Jan 20, 2026
Monthly visitors increased 61% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Nerai Bioscience AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nerai Bioscience AG's valuation, stock price, and market status.
Is Nerai Bioscience AG a public or private company?
Nerai Bioscience AG is a private company.
What is the current stock price of Nerai Bioscience AG?
Nerai Bioscience AG is a private company, so its shares have no public market price. Caplight tracks Nerai Bioscience AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nerai Bioscience AG worth (valuation)?
Valuation information for Nerai Bioscience AG is not publicly available.
Can I buy Nerai Bioscience AG stock?
Nerai Bioscience AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nerai Bioscience AG's last funding round?
Nerai Bioscience AG's most recent funding round was Seed on May 1, 2025.
Who are the main investors in Nerai Bioscience AG?
Key investors in Nerai Bioscience AG include Gebert Rüf Stiftung, Kickfund, Swiss National Science Foundation, Venture Kick.
Will Nerai Bioscience AG IPO soon?
No public IPO plans have been announced for Nerai Bioscience AG.
How can I track Nerai Bioscience AG secondary market activity?
Caplight tracks bids, offers, and trades in Nerai Bioscience AG's shares on secondary markets.